Xtx Topco LTD Catalent, Inc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $268,613 - $291,571	-4,783 Reduced 19.64%	19,565 $1.19 Million
Q2 2024 Aug 12, 2024	BUY	$53.58 - $57.02 $857,119 - $912,148	15,997 Added 191.56%	24,348 $1.37 Million
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $355,418 - $499,556	8,351 New	8,351 $471,000
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $95,643 - $201,914	3,002 Added 44.43%	9,759 $423,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $307,038 - $501,774	6,757 New	6,757 $444,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $396,672 - $518,813	4,549 New	4,549 $488,000
Q2 2021 Aug 12, 2021	SELL	$100.34 - $115.69 $302,525 - $348,805	-3,015 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $306,052 - $377,689	3,015 New	3,015 $318,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.